Revance Therapeutics | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
AbbVie USD 4.81B 1.54B 2024-12
ALKERMES USD 443.75M 333.52M 2024-12
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
Eli Lilly USD 3.46B 2.08B 2025-03
J&J USD 13.63B 8.21B 2025-03
Merck USD 5.22B 114M 2024-12
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
P&G USD 4.66B 1.18B 2025-03
Pacira USD 8.71M 16.82M 2025-03
Supernus Pharmaceuticals USD 26.38M 45.36M 2024-12



Revance Therapeutics L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.